Clinical Study

Clinical study investigates Lacprodan® OPN-10 in infant formula

Format: PDF file | Document type: Clinical Study | Promoted Content

This content is provided by Arla Foods Ingredients Group P/S, and any views and opinions expressed do not necessarily reflect those of


The double-blinded, randomised clinical study has evaluated the effects on immune system development when bovine OPN is added to infant formula. The OPN used for the study was Lacprodan® OPN-10 from Arla Foods Ingredients

We are looking forward to welcoming you and sharing our knowledge at Nutrition & Growth January 30 to February 1, 2014 in Barcelona

About Lacprodan® OPN-10

Lacprodan® OPN-10 is the first OPN product of its kind on the market. Arla Foods Ingredients is currently seeking FDA GRAS approval for the use of Lacprodan® OPN-10 in infant formula. Safety data from the new clinical study will be included in the dossier for submission to the FDA.

Related resources from Arla Foods Ingredients Group P/S

Show more

Supplier info centre